Immunotherapy in non-melanoma skin cancer: updates and new perspectives

Article Page

Keywords: advanced disease, basal cell carcinoma, cutaneous squamous cell carcinoma, immunotherapy, nonmelanoma skin cancer.

Citation: Ascierto PA, Schadendorf D. Immunotherapy in non-melanoma skin cancer: updates and new perspectives. Drugs in Context 2019; 8: 212583. DOI: 10.7573/dic.212583

Contributions: Both authors contributed equally to the preparation of this review. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Disclosure and potential conflicts of interest: Dr Ascierto reports grants and personal fees from BMS, grants and personal fees from Roche-Genentech, personal fees from MSD, grants and personal fees from Array, personal fees from Novartis, personal fees from Merck Serono, personal fees from Pierre Fabre, personal fees from Incyte, personal fees from Genmab, personal fees from NewLink Genetics, personal fees from Medimmune, personal fees from AstraZeneca, personal fees from Syndax, personal fees from Sun Pharma, personal fees from Sanofi, personal fees from Idera, personal fees from Ultimovacs, personal fees from Sandoz, personal fees from Immunocore, outside the submitted work. Dr Schadendorf reports personal fees and other from Sanofi/Regeneron, during the conduct of the study; personal fees from Amgen, personal fees from Boehringer Ingelheim, personal fees from Leo Pharma, personal fees and other from Roche, personal fees and other from Novartis, personal fees from Incyte, personal fees and other from MSD, personal fees from 4SC, personal fees from AstraZeneca, personal fees and other from BMS, personal fees from Pierre Fabre, personal fees and other from Merck-EMD, personal fees from Pfizer, personal fees and other from Philiogen, personal fees from Array, outside the submitted work. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors are available for download at https://www.drugsincontext.com/wp-content/uploads/2019/03/dic.212583-COI.pdf

Acknowledgements: Editorial support provided by Content Ed Net, with the helpful contribution in drafting the text by Elisa Sala, PhD, Medical Writer.

Funding declaration: Editorial assistance was supported by Sanofi Genzyme Italy, with an unrestricted grant.

Copyright: Copyright © 2019 Ascierto PA, Schadendorf D. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.

Correct attribution: Copyright © 2019 Ascierto PA, Schadendorf D. https://doi.org/10.7573/dic.212583. Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0.

Article URL: https://drugsincontext.com/immunotherapy-in-non-melanoma-skin-cancer:-updates-and-new-perspectives

Correspondence: Paolo Antonio Ascierto, UOC Oncologia Medica e Terapie Innovative del Dipartimento Melanoma – Tessuti Molli – Muscolo – Scheletrico e Testa Collo, Istituto Nazionale Tumori Fondazione G. Pascale, Via Mariano Semmola, 53, 80131 Napoli, Italy. p.ascierto@istitutotumori.na.it

Provenance: submitted; externally peer reviewed.

Submitted: 8 February 2019; Peer review comments to author: 28 February 2018; Revised manuscript received: 6 March 2019; Accepted: 6 March 2019; Publication date: 25 March 2019.

Drugs in Context is published by BioExcel Publishing Ltd. Registered office: Plaza Building, Lee High Road, London, England, SE13 5PT.

BioExcel Publishing Limited is registered in England Number 10038393. VAT GB 252 7720 07.

For all manuscript and submissions enquiries, contact the Editor-in-Chief gordon.mallarkey@bioexcelpublishing.com

For all permissions, rights and reprints, contact David Hughes david.hughes@bioexcelpublishing.com

Download free full text PDF